VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Friday, January 9, 2026
Stock Comparison
Novo Nordisk A/S vs ResMed Inc.
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Novo Nordisk A/S
NOVOB · Nasdaq Copenhagen
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Novo Nordisk A/S's moat claims, evidence, and risks.
View NOVOB analysisResMed Inc.
RMD · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Comparison highlights
- Moat score gap: Novo Nordisk A/S leads (85 / 100 vs 76 / 100 for ResMed Inc.).
- Segment focus: Novo Nordisk A/S has 3 segments (71.1% in Diabetes care); ResMed Inc. has 2 segments (87.5% in Sleep and Breathing Health).
- Moat breadth: Novo Nordisk A/S has 5 moat types across 3 domains; ResMed Inc. has 7 across 2.
Primary market context
Novo Nordisk A/S
Diabetes care
Diabetes pharmaceuticals (GLP-1 for type 2 diabetes, insulin, and related therapies)
Global
Payers/providers and patients (via wholesalers/pharmacies/hospitals)
Originator pharma (R&D, regulatory, manufacturing, commercialization)
71.1%
ResMed Inc.
Sleep and Breathing Health
Sleep apnea and respiratory care devices and related consumables (PAP, masks, ventilation) plus connected monitoring services
Global
DME/HME providers, sleep clinics, hospitals, patients
Medical device OEM + connected care software/data services
87.5%
Side-by-side metrics
Moat coverage
Shared moat types
Novo Nordisk A/S strengths
ResMed Inc. strengths
Segment mix
Novo Nordisk A/S segments
Full profile >Diabetes care
Oligopoly
Obesity care
Duopoly
Rare disease
Oligopoly
ResMed Inc. segments
Full profile >Sleep and Breathing Health
Oligopoly
Residential Care Software
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listLooking for expansion-stage stocks?
Proven models entering the expansion stage with unit economics that work.
View expansion-stage stocksCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.